102 related articles for article (PubMed ID: 1719286)
1. Cellular electrophysiological effects of the class III antiarrhythmic agents sematilide and clofilium on rabbit atrial tissues.
Argentieri TM; Carroll MS; Sullivan ME
J Cardiovasc Pharmacol; 1991 Jul; 18(1):167-74. PubMed ID: 1719286
[TBL] [Abstract][Full Text] [Related]
2. Effects of sematilide, a novel class III antiarrhythmic agent, on action potential in guinea pig atrium.
Ishii Y; Muraki K; Kurihara A; Imaizumi Y; Watanabe M
Jpn J Pharmacol; 1995 Jun; 68(2):175-82. PubMed ID: 7563974
[TBL] [Abstract][Full Text] [Related]
3. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
[TBL] [Abstract][Full Text] [Related]
4. Effects of sematilide, a novel class III antiarrhythmic agent, on membrane currents in rabbit atrial myocytes.
Ishii Y; Muraki K; Kurihara A; Imaizumi Y; Watanabe M
Eur J Pharmacol; 1997 Jul; 331(2-3):295-302. PubMed ID: 9274992
[TBL] [Abstract][Full Text] [Related]
5. Rate-dependent effects of sematilide on ventricular monophasic action potential duration and delayed rectifier K+ current in rabbits.
Beatch GN; Davis DR; Laganière S; Williams BA
J Cardiovasc Pharmacol; 1996 Nov; 28(5):618-30. PubMed ID: 8945674
[TBL] [Abstract][Full Text] [Related]
6. Comparison of direct negative chronotropic and positive inotropic effects of sematilide to those of E-4031 and MS-551 and the reverse frequency-dependent prolongation of cardiac refractoriness of sematilide.
Yamada A; Motomura S; Hashimoto K
J Cardiovasc Pharmacol; 1996 Jan; 27(1):159-66. PubMed ID: 8656651
[TBL] [Abstract][Full Text] [Related]
7. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R
Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
[TBL] [Abstract][Full Text] [Related]
8. Effects of sematilide, a novel class III antiarrhythmic agent, on delayed rectifier K+ current in guinea pig atrial myocytes.
Ishii Y; Muraki K; Kurihara A; Imaizumi Y; Watanabe M
Jpn J Pharmacol; 1996 Aug; 71(4):361-5. PubMed ID: 8886937
[TBL] [Abstract][Full Text] [Related]
9. Rate-dependent effects of sematilide on action potential duration in isolated guinea pig ventricular myocytes.
Sawanobori T; Adaniya H; Namiki T; Hiraoka M
J Pharmacol Exp Ther; 1994 Oct; 271(1):302-10. PubMed ID: 7965729
[TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic and proarrhythmic effects of sematilide in canine ventricular arrhythmia models.
Xue YX; Eto K; Akie Y; Hashimoto K
Jpn J Pharmacol; 1996 Feb; 70(2):129-38. PubMed ID: 8866750
[TBL] [Abstract][Full Text] [Related]
11. The electrophysiological effects of dicentrine on the conduction system of rabbit heart.
Young ML; Su MJ; Wu MH; Chen CC
Br J Pharmacol; 1994 Sep; 113(1):69-76. PubMed ID: 7812635
[TBL] [Abstract][Full Text] [Related]
12. Cellular electrophysiology of clofilium, a new antifibrillatory agent, in normal and ischemic canine Purkinje fibers.
Steinberg MI; Sullivan ME; Wiest SA; Rockhold FW; Molloy BB
J Cardiovasc Pharmacol; 1981; 3(4):881-95. PubMed ID: 6167818
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic effects of ambasilide (LU 47110), a novel class III antiarrhythmic agent, on the properties of isolated rabbit and canine cardiac muscle.
Takanaka C; Sarma JS; Singh BN
J Cardiovasc Pharmacol; 1992 Feb; 19(2):290-8. PubMed ID: 1376799
[TBL] [Abstract][Full Text] [Related]
14. Antifibrillatory effects of clofilium in the rabbit isolated heart.
Friedrichs GS; Chi L; Green AL; Lucchesi BR
Br J Pharmacol; 1994 Sep; 113(1):209-15. PubMed ID: 7812612
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog.
Leboeuf J; Basiez M; Massingham R
Br J Pharmacol; 1993 Sep; 110(1):23-8. PubMed ID: 8220882
[TBL] [Abstract][Full Text] [Related]
16. Effect of nifedipine and AQ-A 39 on the sinoatrial and atrioventricular nodes of the rabbit and their antiarrhythmic action on atrioventricular nodal reentrant tachycardia.
Senges J; Rizos I; Brachmann J; Anders G; Jauernig R; Hamman HD; Kübler W
Cardiovasc Res; 1983 Mar; 17(3):132-44. PubMed ID: 6871903
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and cardiac electrophysiological activity of aryl-substituted derivatives of the class III antiarrhythmic agent sematilide. Potential class I/III agents.
Phillips GB; Morgan TK; Nickisch K; Lind JM; Gomez RP; Wohl RA; Argentieri TM; Sullivan ME
J Med Chem; 1990 Feb; 33(2):627-33. PubMed ID: 2299628
[TBL] [Abstract][Full Text] [Related]
18. Selectivity of class-III antiarrhythmic action of clofilium in guinea pig ventricular myocytes.
Li Q; Himmel HM; Ravens U
J Cardiovasc Pharmacol; 1996 Mar; 27(3):401-10. PubMed ID: 8907802
[TBL] [Abstract][Full Text] [Related]
19. Effects of bepridil on the electrophysiologic properties of isolated canine and rabbit myocardial fibers.
Kato R; Singh BN
Am Heart J; 1986 Feb; 111(2):271-9. PubMed ID: 3484892
[TBL] [Abstract][Full Text] [Related]
20. Electrophysiologic activity and antiarrhythmic efficacy of CK-3579, a new class III antiarrhythmic agent with beta-adrenergic blocking properties.
Argentieri TM; Troy HH; Carroll MS; Doroshuk CM; Sullivan ME
J Cardiovasc Pharmacol; 1993 Apr; 21(4):647-55. PubMed ID: 7681912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
